Skip to Main Content

Paper Details

PRMT1-Mediated Translation Regulation Is a Crucial Vulnerability of Cancer.
Cancer Res
25
2017
-, Cancer, PRMT1, Prmt1, Rb, arginine, cancer, cancers, deficient cells, downstream targets, functional networks, human, human cancer cell line, murine, murine p53/Rb-null osteosarcomas, osteosarcomas, p53, p53-deficient cells, protein arginine methyltransferase Prmt1, shRNA, tumor
Author NameAffiliation
Francisca VazquezThe Broad Institute of Harvard and MIT
Barbara A WeirThe Broad Institute of Harvard and MIT
Barbara A WeirThe Broad Institute of Harvard and MIT
Aviad TsherniakThe Broad Institute of Harvard and MIT
Aviad TsherniakThe Broad Institute of Harvard and MIT
Glenn S CowleyThe Broad Institute of Harvard and MIT
Huafeng XieBoston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School
William C HahnThe Broad Institute of Harvard and MIT
William C HahnDana-Farber Cancer Institute
William C HahnThe Broad Institute of Harvard and MIT
William C HahnDana-Farber Cancer Institute
Stuart H OrkinBoston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Stem Cell Institute, Harvard Medical School
Stuart H OrkinHoward Hughes Medical Institute
  • 1 - 13

Datasets

Release 1.2